Nifty

:

24579.60

Sensex

:

80157.88

-45.45 (-0.18%)
-206.61 (-0.26%)

Login

Nifty
Sensex

:
:

24579.60
80157.88

-45.45 (-0.18%)
-206.61 (-0.26%)

Sequent Scientific Ltd.

Pharmaceuticals & Drugs - Veterinary

Rating :

64/99

BSE: 512529 | NSE: SEQUENT

Watchlist

NSE BSE

171.81

02-Sep-2025

Open
High
Low
Previous Close

171
174.68
169.92
170.46

Volume
Traded Value (lacs)
52 Week High
52 Week Low

330590
57006201.94
240.7
117.35

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,303.26
144.99
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,680.56
N/A
6.88

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.52
2.64
2.97

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.85
-5.42
67.75

PAT CAGR (%)

10 Years
5 Years
3 Years

4.27
-25.52
-

P:E (Median)

8 Years
5 Years
3 Years

46.32
62.83
-

P:BV (Average)

8 Years
5 Years
3 Years

4.35
5.38
4.86

EV:EBITDA (Average)

8 Years
5 Years
3 Years

43.81
60.04
82.27

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS -1.44 0.88 2.78 5.03
P/E Ratio -119.31 195.24 61.80 34.16
Revenue 1366 1551 1718 1932
EBITDA 61 162 207 303
Net Income -36 22 69 125
ROA -2.3 1.4 6.9 9
P/B Ratio 3.94 6.11 5.79 5.07
ROE -5.29 3.22 11.16 15.86
FCFF -45 -5 79 125
FCFF Yield -0.88 -0.09 1.53 2.44
Net Debt 415 412
BVPS 43.59 28.14 29.66 33.91

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 41.07 57.67 -28.78% 42.33 36.77 15.12% 36.27 42.21 -14.07% 41.99 49.12 -14.52%
Expenses 43.11 59.65 -27.73% 45.15 42.51 6.21% 40.75 46.36 -12.10% 44.09 56.83 -22.42%
EBITDA -2.04 -1.98 - -2.82 -5.74 - -4.48 -4.15 - -2.10 -7.71 -
EBIDTM -4.97% -3.43% -6.66% -15.61% -12.35% -9.83% -5.00% -15.70%
Other Income 11.48 10.84 5.90% 12.27 12.98 -5.47% 11.88 13.44 -11.61% 15.95 9.87 61.60%
Interest 1.08 0.81 33.33% 0.99 1.03 -3.88% 1.17 1.15 1.74% 1.00 1.21 -17.36%
Depreciation 2.33 2.00 16.50% 2.30 2.11 9.00% 2.24 2.05 9.27% 2.12 2.35 -9.79%
PBT 4.78 6.05 -20.99% 5.91 4.10 44.15% 3.68 6.09 -39.57% 6.41 -1.40 -
Tax 1.41 1.55 -9.03% 1.68 0.34 394.12% 0.87 1.51 -42.38% 2.15 -0.48 -
PAT 3.37 4.50 -25.11% 4.23 3.76 12.50% 2.81 4.58 -38.65% 4.26 -0.92 -
PATM 8.21% 7.80% 9.99% 10.23% 7.75% 10.85% 10.15% -1.87%
EPS 0.13 0.18 -27.78% 0.17 0.15 13.33% 0.11 0.18 -38.89% 0.17 -0.04 -

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 441.42 390.21 13.12% 401.70 361.20 11.21% 390.81 329.36 18.66% 368.65 345.97 6.56%
Expenses 389.23 348.26 11.76% 355.46 328.93 8.07% 356.31 307.11 16.02% 329.55 330.84 -0.39%
EBITDA 52.19 41.95 24.41% 46.24 32.27 43.29% 34.50 22.25 55.06% 39.10 15.13 158.43%
EBIDTM 11.82% 10.75% 11.51% 8.93% 8.83% 6.76% 10.61% 4.37%
Other Income 3.87 2.68 44.40% 1.66 4.00 -58.50% 5.84 4.52 29.20% 4.51 1.65 173.33%
Interest 14.16 16.38 -13.55% 15.13 12.44 21.62% 14.95 12.58 18.84% 14.29 12.58 13.59%
Depreciation 15.13 16.25 -6.89% 16.12 16.48 -2.18% 16.98 15.46 9.83% 17.10 15.36 11.33%
PBT 25.52 12.00 112.67% 16.31 2.64 517.80% 8.10 1.49 443.62% 7.90 -3.09 -
Tax 7.95 2.94 170.41% 5.93 1.37 332.85% 1.62 -9.19 - 1.56 3.79 -58.84%
PAT 17.57 9.06 93.93% 10.38 1.27 717.32% 6.48 10.68 -39.33% 6.34 -6.88 -
PATM 3.98% 2.32% 2.58% 0.35% 1.66% 3.24% 1.72% -1.99%
EPS 0.57 0.26 119.23% 0.37 -0.04 - 0.14 0.33 -57.58% 0.10 -0.34 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 161.66 178.26 168.52 222.69 219.63 265.46 227.33 166.26 271.20 105.87 394.59 Net Sales Growth -12.98% 5.78% -24.33% 1.39% -17.26% 16.77% 36.73% -38.69% 156.16% -73.17% Cost Of Goods Sold 87.11 105.50 107.89 135.92 108.66 108.87 113.04 94.62 161.37 72.47 218.33 Gross Profit 74.55 72.76 60.63 86.77 110.97 156.59 114.29 71.64 109.83 33.40 176.26 GP Margin 46.12% 40.82% 35.98% 38.96% 50.53% 58.99% 50.27% 43.09% 40.50% 31.55% 44.67% Total Expenditure 173.10 189.64 195.18 249.09 231.59 241.50 205.10 163.57 258.06 121.27 359.06 Power & Fuel Cost - 12.53 12.89 13.93 11.96 12.77 12.73 8.52 2.32 2.14 17.98 % Of Sales - 7.03% 7.65% 6.26% 5.45% 4.81% 5.60% 5.12% 0.86% 2.02% 4.56% Employee Cost - 35.05 30.05 36.66 27.38 22.42 17.10 10.71 25.12 17.90 38.84 % Of Sales - 19.66% 17.83% 16.46% 12.47% 8.45% 7.52% 6.44% 9.26% 16.91% 9.84% Manufacturing Exp. - 15.48 22.39 39.30 48.21 58.70 51.52 41.13 15.87 14.85 56.50 % Of Sales - 8.68% 13.29% 17.65% 21.95% 22.11% 22.66% 24.74% 5.85% 14.03% 14.32% General & Admin Exp. - 12.24 12.12 14.79 16.29 15.28 6.90 7.15 13.02 9.92 15.19 % Of Sales - 6.87% 7.19% 6.64% 7.42% 5.76% 3.04% 4.30% 4.80% 9.37% 3.85% Selling & Distn. Exp. - 2.77 1.55 1.85 2.16 4.02 2.11 1.04 0.83 0.47 4.03 % Of Sales - 1.55% 0.92% 0.83% 0.98% 1.51% 0.93% 0.63% 0.31% 0.44% 1.02% Miscellaneous Exp. - 6.07 8.29 6.65 16.94 19.45 1.68 0.40 39.53 3.53 4.03 % Of Sales - 3.41% 4.92% 2.99% 7.71% 7.33% 0.74% 0.24% 14.58% 3.33% 2.08% EBITDA -11.44 -11.38 -26.66 -26.40 -11.96 23.96 22.23 2.69 13.14 -15.40 35.53 EBITDA Margin -7.08% -6.38% -15.82% -11.86% -5.45% 9.03% 9.78% 1.62% 4.85% -14.55% 9.00% Other Income 51.58 50.94 45.98 28.29 38.86 31.30 14.56 13.96 24.67 19.07 15.55 Interest 4.24 3.96 4.36 2.51 1.61 2.68 5.04 3.22 4.54 0.42 16.44 Depreciation 8.99 8.66 8.94 9.12 9.59 9.13 8.95 7.22 14.37 3.25 24.18 PBT 20.78 26.93 6.01 -9.75 15.69 43.45 22.81 6.20 18.90 -0.01 10.46 Tax 6.11 6.25 -0.86 -3.67 0.89 8.77 1.47 -1.38 2.87 0.00 0.07 Tax Rate 29.40% 28.34% 358.33% 37.64% 5.67% 21.45% 6.44% -22.26% 0.70% 0.00% 0.67% PAT 14.67 15.79 0.62 -6.08 14.80 32.11 21.34 7.59 406.41 -0.01 10.39 PAT before Minority Interest 14.67 15.79 0.62 -6.08 14.80 32.11 21.34 7.59 406.41 -0.01 10.39 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.07% 8.86% 0.37% -2.73% 6.74% 12.10% 9.39% 4.57% 149.86% -0.01% 2.63% PAT Growth 23.07% 2,446.77% - - -53.91% 50.47% 181.16% -98.13% - - EPS 0.59 0.63 0.02 -0.24 0.59 1.28 0.85 0.30 16.24 0.00 0.42

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,602.58 1,551.37 1,369.73 1,420.91 1,412.82 1,361.62 1,179.24 1,039.31 1,030.59 683.57 624.98 Net Sales Growth 12.32% 13.26% -3.60% 0.57% 3.76% 15.47% 13.46% 0.85% 50.77% 9.37% Cost Of Goods Sold 832.11 811.85 759.74 833.77 793.00 694.65 605.05 543.01 554.23 356.70 311.71 Gross Profit 770.47 739.52 609.98 587.14 619.82 666.96 574.19 496.30 476.36 326.87 313.27 GP Margin 48.08% 47.67% 44.53% 41.32% 43.87% 48.98% 48.69% 47.75% 46.22% 47.82% 50.12% Total Expenditure 1,430.55 1,392.50 1,308.32 1,408.95 1,303.43 1,151.68 1,008.92 914.37 919.10 643.03 568.27 Power & Fuel Cost - 32.98 35.46 42.45 33.86 28.75 24.73 23.06 14.66 12.77 26.51 % Of Sales - 2.13% 2.59% 2.99% 2.40% 2.11% 2.10% 2.22% 1.42% 1.87% 4.24% Employee Cost - 281.12 250.57 258.38 231.37 187.22 165.06 145.95 132.07 106.22 88.62 % Of Sales - 18.12% 18.29% 18.18% 16.38% 13.75% 14.00% 14.04% 12.81% 15.54% 14.18% Manufacturing Exp. - 67.65 73.58 86.95 93.67 96.18 83.24 77.73 59.07 57.63 72.14 % Of Sales - 4.36% 5.37% 6.12% 6.63% 7.06% 7.06% 7.48% 5.73% 8.43% 11.54% General & Admin Exp. - 87.64 78.10 75.80 66.90 58.40 56.37 58.35 70.92 48.60 36.44 % Of Sales - 5.65% 5.70% 5.33% 4.74% 4.29% 4.78% 5.61% 6.88% 7.11% 5.83% Selling & Distn. Exp. - 69.43 56.70 58.00 57.11 50.00 45.16 36.29 36.87 28.78 17.46 % Of Sales - 4.48% 4.14% 4.08% 4.04% 3.67% 3.83% 3.49% 3.58% 4.21% 2.79% Miscellaneous Exp. - 41.83 54.16 53.60 27.52 36.47 29.32 29.98 51.29 32.34 17.46 % Of Sales - 2.70% 3.95% 3.77% 1.95% 2.68% 2.49% 2.88% 4.98% 4.73% 2.46% EBITDA 172.03 158.87 61.41 11.96 109.39 209.94 170.32 124.94 111.49 40.54 56.71 EBITDA Margin 10.73% 10.24% 4.48% 0.84% 7.74% 15.42% 14.44% 12.02% 10.82% 5.93% 9.07% Other Income 15.88 17.62 10.96 6.39 10.86 10.49 10.09 8.67 17.20 11.08 14.30 Interest 58.53 60.75 48.09 35.52 15.77 24.38 35.71 32.80 39.70 28.34 38.56 Depreciation 65.33 66.45 61.54 55.69 51.54 50.60 50.62 41.92 53.30 40.07 46.22 PBT 57.83 49.28 -37.26 -72.86 52.93 145.45 94.08 58.88 35.70 -16.80 -13.77 Tax 17.06 12.05 -25.03 -15.68 8.17 32.18 12.03 2.01 13.46 -0.41 2.62 Tax Rate 29.50% 27.20% 45.80% 11.39% 15.44% 23.55% 12.79% 3.41% 3.03% 2.44% -19.03% PAT 40.77 21.88 -35.87 -121.16 40.95 95.44 69.91 48.66 421.57 -13.83 -18.47 PAT before Minority Interest 29.68 32.26 -29.61 -121.98 44.76 104.45 82.05 56.88 430.83 -16.39 -16.39 Minority Interest -11.09 -10.38 -6.26 0.82 -3.81 -9.01 -12.14 -8.22 -9.26 2.56 -2.08 PAT Margin 2.54% 1.41% -2.62% -8.53% 2.90% 7.01% 5.93% 4.68% 40.91% -2.02% -2.96% PAT Growth 188.54% - - - -57.09% 36.52% 43.67% -88.46% - - EPS 1.63 0.87 -1.43 -4.84 1.64 3.81 2.79 1.94 16.84 -0.55 -0.74

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,142.65 1,087.23 1,058.36 1,041.09 1,029.51 886.22 917.79 948.62 1,257.33 1,205.88 Share Capital 50.06 49.89 49.89 49.67 49.67 49.67 49.37 48.75 48.75 47.65 Total Reserves 995.80 960.03 952.25 944.32 972.07 822.45 849.53 882.29 1,193.03 1,134.19 Non-Current Liabilities 22.91 24.21 -9.43 19.26 4.80 11.50 36.20 19.01 38.28 42.08 Secured Loans 0.00 0.00 0.00 0.00 0.00 15.16 20.61 0.00 13.98 23.82 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 30.93 35.80 2.54 24.51 6.59 4.09 22.30 24.39 28.88 22.84 Current Liabilities 75.56 98.16 61.61 89.56 96.62 105.24 79.87 26.69 168.71 109.89 Trade Payables 22.93 37.14 36.71 57.56 58.75 64.34 52.60 24.56 69.96 73.64 Other Current Liabilities 7.60 13.95 4.67 5.20 2.85 9.30 6.01 1.91 35.29 20.85 Short Term Borrowings 44.38 46.45 19.10 15.50 5.22 14.39 19.27 0.00 63.22 15.04 Short Term Provisions 0.64 0.61 1.13 11.30 29.81 17.22 1.99 0.21 0.24 0.36 Total Liabilities 1,241.12 1,209.60 1,110.54 1,149.91 1,130.93 1,002.96 1,033.86 994.32 1,464.32 1,357.85 Net Block 46.18 42.52 56.72 66.90 65.78 69.41 52.42 23.68 181.67 169.60 Gross Block 94.39 87.15 110.96 113.09 102.86 99.30 73.33 37.61 230.34 193.00 Accumulated Depreciation 48.21 44.63 54.24 46.19 37.08 29.89 20.90 13.93 48.67 23.40 Non Current Assets 1,133.60 1,104.41 1,025.43 995.04 985.95 879.01 946.46 853.77 1,095.85 1,056.39 Capital Work in Progress 6.64 5.14 2.20 1.40 4.34 3.72 0.03 3.12 32.26 19.97 Non Current Investment 647.25 640.30 632.47 658.47 685.11 738.95 788.16 672.67 834.62 834.87 Long Term Loans & Adv. 433.30 415.89 333.48 267.65 230.43 65.53 83.27 138.79 26.79 23.08 Other Non Current Assets 0.22 0.56 0.56 0.61 0.29 1.39 22.57 15.51 20.52 8.86 Current Assets 107.53 96.78 75.02 154.86 144.99 123.95 87.41 140.54 368.46 301.47 Current Investments 0.07 0.11 0.05 0.14 0.07 18.75 0.10 13.98 62.28 62.29 Inventories 25.05 34.54 47.95 67.99 45.79 31.42 25.33 13.83 62.53 56.19 Sundry Debtors 68.93 44.79 13.65 52.42 61.44 40.79 42.90 78.47 113.03 73.75 Cash & Bank 0.41 0.96 0.18 12.89 0.74 3.72 1.88 3.04 3.06 4.80 Other Current Assets 13.06 2.84 1.00 1.74 36.96 29.27 17.21 31.22 127.56 104.45 Short Term Loans & Adv. 9.78 13.54 12.21 19.69 33.40 25.66 15.65 30.09 114.68 86.38 Net Current Assets 31.97 -1.38 13.42 65.31 48.37 18.71 7.54 113.85 199.75 191.58 Total Assets 1,241.13 1,201.19 1,100.45 1,149.90 1,130.94 1,002.96 1,033.87 994.31 1,464.31 1,357.86

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 704.47 656.56 698.78 692.10 727.65 687.10 706.69 647.58 976.79 945.71 Share Capital 50.06 49.89 49.89 49.67 49.67 49.67 49.37 48.75 48.75 47.65 Total Reserves 557.62 529.37 592.57 595.33 670.21 623.34 638.43 581.25 912.49 874.01 Non-Current Liabilities 263.19 172.55 175.81 209.11 153.58 216.46 214.75 227.13 246.20 299.72 Secured Loans 271.31 123.76 113.95 87.25 62.52 108.88 126.94 85.14 141.76 197.50 Unsecured Loans 2.56 18.96 36.16 35.21 31.18 41.18 20.90 18.40 23.38 13.82 Long Term Provisions 61.98 72.22 21.47 55.95 27.19 13.16 30.50 28.54 34.76 28.66 Current Liabilities 538.54 645.54 558.76 537.35 513.11 514.86 440.41 430.93 663.55 290.37 Trade Payables 256.71 251.22 244.34 258.05 226.91 220.38 209.35 160.49 203.04 143.94 Other Current Liabilities 67.96 118.60 109.57 78.99 100.64 104.98 87.80 106.52 259.26 83.23 Short Term Borrowings 160.87 245.87 182.09 159.54 102.91 147.12 127.36 152.41 194.70 56.04 Short Term Provisions 52.99 29.86 22.76 40.77 82.66 42.38 15.90 11.51 6.54 7.17 Total Liabilities 1,572.09 1,531.05 1,483.76 1,486.57 1,443.00 1,463.16 1,402.10 1,342.62 1,903.76 1,538.02 Net Block 586.03 591.95 605.31 564.44 535.66 576.57 498.14 475.97 684.33 586.48 Gross Block 1,003.14 959.12 939.83 825.09 753.25 762.46 638.06 581.74 789.60 643.70 Accumulated Depreciation 417.11 367.17 334.52 260.64 217.60 185.89 139.91 105.77 105.27 57.22 Non Current Assets 664.82 689.64 693.88 678.16 676.33 738.86 795.99 804.61 1,176.02 1,047.48 Capital Work in Progress 15.64 15.93 55.28 11.63 30.79 13.42 22.61 18.04 32.55 23.52 Non Current Investment 0.01 0.89 0.01 36.79 76.94 131.29 179.65 221.73 363.97 360.58 Long Term Loans & Adv. 55.26 69.47 21.74 53.92 32.15 14.40 32.27 31.01 37.51 30.35 Other Non Current Assets 7.89 11.41 11.54 11.37 0.79 3.18 63.31 57.86 57.66 46.54 Current Assets 906.46 829.49 779.79 808.41 766.68 724.30 606.12 538.01 727.74 490.54 Current Investments 0.07 2.61 0.05 1.44 5.66 40.18 0.47 17.34 64.12 66.98 Inventories 385.32 346.23 346.09 347.97 264.36 219.42 200.10 158.57 160.81 135.08 Sundry Debtors 363.17 335.63 340.96 329.24 346.14 318.76 278.25 258.35 254.62 192.39 Cash & Bank 69.07 69.83 41.75 59.25 56.20 75.83 72.04 42.45 47.40 25.30 Other Current Assets 88.83 10.37 7.74 7.68 94.34 70.12 55.26 61.30 200.79 70.80 Short Term Loans & Adv. 80.23 64.81 43.21 62.83 77.52 55.33 46.75 56.05 54.48 46.69 Net Current Assets 367.92 183.95 221.03 271.06 253.57 209.44 165.71 107.08 64.19 200.17 Total Assets 1,571.28 1,519.13 1,473.67 1,486.57 1,443.01 1,463.16 1,402.11 1,342.62 1,903.76 1,538.02

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -1.13 -26.94 37.75 9.36 2.34 30.20 73.80 -4.02 -24.04 100.02 PBT 22.05 -0.24 -9.75 15.69 43.45 22.81 6.20 409.27 -0.01 10.46 Adjustment -18.47 -18.19 -0.49 -6.38 1.12 1.74 -2.19 -392.74 20.30 33.58 Changes in Working Capital -8.01 -10.77 48.68 1.81 -25.47 7.84 70.32 -21.10 -42.97 56.92 Cash after chg. in Working capital -4.43 -29.20 38.45 11.12 19.09 32.39 74.34 -4.57 -22.68 100.95 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 3.31 2.25 -0.70 -1.75 -16.76 -2.19 -0.54 0.55 -1.36 -0.93 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -0.44 5.47 -50.70 -4.25 16.55 -17.68 -114.06 15.60 -46.84 -359.41 Net Fixed Assets -8.74 20.87 1.33 -7.29 -4.18 -29.66 -32.63 221.87 -49.63 97.97 Net Investments -6.91 -7.89 26.09 26.57 72.52 30.56 -101.61 210.25 0.26 -713.97 Others 15.21 -7.51 -78.12 -23.53 -51.79 -18.58 20.18 -416.52 2.53 256.59 Cash from Financing Activity 0.67 22.32 0.24 7.25 -21.33 -10.71 40.34 -11.78 70.97 247.38 Net Cash Inflow / Outflow -0.90 0.84 -12.71 12.36 -2.44 1.81 0.07 -0.19 0.09 -12.01 Opening Cash & Equivalents 0.93 0.08 12.80 0.44 2.87 1.07 1.00 1.19 1.10 13.11 Closing Cash & Equivalent 0.03 0.93 0.08 12.80 0.44 2.87 1.07 1.00 1.19 1.10

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 83.36 30.59 16.81 30.59 114.75 115.33 116.02 45.24 -7.19 -0.05 PBT 44.31 -54.65 -137.66 52.93 145.45 94.08 58.88 445.79 -16.80 -13.77 Adjustment 155.05 144.97 220.72 93.73 83.98 91.41 84.47 -313.85 123.31 83.81 Changes in Working Capital -88.38 -45.67 -51.61 -89.30 -70.89 -58.30 -27.95 -77.87 -104.37 -71.46 Cash after chg. in Working capital 110.97 44.65 31.45 57.36 158.55 127.18 115.40 54.06 2.14 -1.42 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -27.61 -14.06 -14.64 -26.77 -43.79 -11.85 0.62 -8.83 -9.33 1.37 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -24.78 -5.92 -64.96 -95.57 9.65 -72.27 -67.69 7.17 -116.18 -315.83 Net Fixed Assets -8.74 20.87 1.33 -7.29 -4.18 -29.66 -32.63 221.87 -49.63 97.97 Net Investments -6.91 -7.89 26.09 26.57 72.52 30.56 -101.61 210.25 0.26 -713.97 Others -9.13 -18.90 -92.38 -114.85 -58.69 -73.17 66.55 -424.95 -66.81 300.17 Cash from Financing Activity -60.73 -1.44 32.23 67.26 -138.75 -42.75 -20.08 -56.96 147.44 308.69 Net Cash Inflow / Outflow -2.15 23.24 -15.92 2.29 -14.35 0.31 28.25 -4.55 24.07 -7.19 Opening Cash & Equivalents 64.81 41.57 57.50 53.74 68.10 67.79 39.54 44.10 20.03 21.85 Closing Cash & Equivalent 62.66 64.81 41.57 57.50 53.74 68.10 67.79 39.54 44.10 20.03

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 41.78 40.49 40.18 40.02 41.14 35.11 36.41 38.20 50.95 49.61 ROA 1.29% 0.05% -0.54% 1.30% 3.01% 2.10% 0.75% 33.06% 0.00% 1.03% ROE 1.54% 0.06% -0.61% 1.47% 3.39% 2.41% 0.83% 37.41% 0.00% 1.59% ROCE 2.24% 0.37% -0.68% 1.65% 4.45% 2.96% 0.99% 36.09% 0.03% 3.07% Fixed Asset Turnover 2.01 1.74 2.01 2.04 2.66 2.66 3.00 2.05 0.52 1.65 Receivable days 113.81 61.84 53.54 94.31 69.43 66.55 132.93 127.17 310.76 77.04 Inventory Days 59.64 87.31 93.97 94.25 52.44 45.13 42.89 50.71 197.54 54.96 Payable days 103.91 124.91 126.58 195.35 206.34 103.60 86.82 78.05 239.99 74.47 Cash Conversion Cycle 69.55 24.24 20.93 -6.79 -84.46 8.08 88.99 99.83 268.31 57.53 Total Debt/Equity 0.04 0.05 0.02 0.02 0.01 0.04 0.05 0.00 0.07 0.04 Interest Cover 6.57 0.95 -2.88 10.75 16.26 5.53 2.93 91.09 0.97 1.64

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 24.28 23.22 25.76 25.97 28.98 27.10 27.86 25.85 39.44 38.69 ROA 2.08% -1.96% -8.21% 3.06% 7.19% 5.73% 4.14% 26.54% -0.95% -1.33% ROE 5.44% -4.85% -18.95% 6.56% 15.00% 12.06% 8.63% 54.15% -1.74% -3.35% ROCE 9.30% -0.60% -9.71% 7.01% 16.24% 12.59% 9.24% 41.28% 0.87% 2.72% Fixed Asset Turnover 1.63 1.49 1.65 1.83 1.80 1.72 1.74 1.51 0.96 1.03 Receivable days 79.76 87.51 84.11 85.48 89.12 90.45 92.53 90.49 118.40 87.75 Inventory Days 83.50 89.54 87.10 77.50 64.84 63.56 61.85 56.34 78.37 65.41 Payable days 114.18 119.04 109.97 111.61 117.51 80.72 75.36 77.04 104.11 77.28 Cash Conversion Cycle 49.09 58.01 61.25 51.38 36.45 73.29 79.02 69.78 92.66 75.87 Total Debt/Equity 0.73 0.78 0.62 0.49 0.31 0.51 0.47 0.48 0.43 0.34 Interest Cover 1.73 -0.14 -2.88 4.36 6.60 3.63 2.80 12.19 0.41 0.64

Top Investors:

quant mutual fund - quant healthcare fund

ashoka whiteoak icav - ashoka whiteoak india oppor

investor education and protection fund (iepf)

Annual Reports:

News Update:

Sequent Scientific - Quarterly Results
8th Aug 2025, 12:49 PM

Read More
SeQuent secures approvals from NSE and BSE for proposed merger with Viyash Life Sciences
29th May 2025, 12:59 PM

Under the agreed terms, shareholders of Viyash will receive 56 SeQuent shares for every 100 Viyash shares held
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback